Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Giant Cell Tumor of Bone 2Neoplasm, Residual 1Multiple Myeloma 1Leiomyoma 1Disease Progression 1

Interventions

Denosumab 6Vitamin D 2Calcium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Giant Cell Tumor of Bone × Vitamin D × Clear all
NCT00396279 2022-11-08

Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone

Amgen

Phase 2 Completed
37 enrolled 13 charts

Giant Cell Tumor of Bone

NCT04255576 2022-10-14

Efficacy and Safety of JMT103 in Patients With Giant Cell Tumor of Bone

Shanghai JMT-Bio Inc.

Phase 1/2 Unknown
139 enrolled

Giant Cell Tumor of Bone

Data powered by HemOnc (CC BY 4.0) Colophon âš¡